|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
BENDAMUSTINE |
L01AA09 |
DE
|
POM
|
09-04-2018 |
DE/H/1250/001/ |
29-06-2014 |
VALID
|
|
BENPROPERINE |
R05DB02 |
DE
|
POM
|
25-01-2022 |
|
|
VALID
|
|
BENRALIZUMAB |
R03DX10 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004433 |
08-02-2018 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
DE
|
POM
|
22-02-2024 |
|
|
VALID
|
|
BETAINE |
A16AA06 |
DE
|
POM
|
26-07-2024 |
|
|
VALID
|
|
BETAMETHASONE |
D07AC01 |
DE
|
POM
|
|
|
|
VALID
|
|
BETAMETHASONE |
R01AD06 |
DE
|
POM
|
|
|
|
VALID
|
|
BETULAE CORTEX |
D03AX13 |
DE
|
POM
|
|
|
|
VALID
|
|
BEVACIZUMAB |
S01LA08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
BEXAROTENE |
L01XF03 |
DE
|
POM
|
|
|
|
VALID
|
|
BEZAFIBRATE |
C10AB02 |
DE
|
POM
|
|
|
|
VALID
|
|
BLINATUMOMAB |
L01FX07 |
DE
|
POM
|
|
|
|
VALID
|
|
BORTEZOMIB |
L01XG01 |
DE
|
POM
|
09-03-2020 |
|
|
VALID
|
|
BOSENTAN |
C02KX01 |
DE
|
POM
|
12-07-2023 |
DE/H/5017/002/ |
03-06-2015 |
VALID
|
|
BOSUTINIB |
L01EA04 |
DE
|
POM
|
13-07-2023 |
|
|
VALID
|
|
BRIGATINIB |
L01ED04 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
BRIMONIDINE |
S01EA05 |
DE
|
POM
|
21-10-2019 |
DK/H/1269/001/P/001 |
06-04-2018 |
VALID
|
|
BRINZOLAMIDE |
S01EC04 |
DE
|
POM
|
|
|
|
VALID
|
|
BRIVARACETAM |
N03AX23 |
DE
|
POM
|
|
|
|
VALID
|
|
BRODALUMAB |
L04AC12 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/003959 |
17-07-2017 |
VALID
|
|
BROLUCIZUMAB |
S01LA06 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
BUDESONIDE |
A07EA06 |
DE
|
POM
|
|
|
|
VALID
|
|
BUDESONIDE |
R01AD05 |
DE
|
POM
|
17-05-2018 |
DE/H/0933/002/ |
24-05-2013 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
BUPIVACAINE |
N01BB01 |
DE
|
POM
|
18-01-2021 |
DE/H/2600/001/DC |
24-08-2010 |
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
DE
|
POM
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
BUROSUMAB |
M05BX05 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004275 |
19-02-2018 |
VALID
|
|
CABERGOLINE |
G02CB03 |
DE
|
POM
|
21-10-2019 |
SE/H/0648/001/P/001 |
18-06-2018 |
VALID
|
|
CABOZANTINIB |
L01EX07 |
DE
|
POM
|
26-02-2020 |
|
|
VALID
|
|
CAFFEINE |
N06BC01 |
DE
|
POM
|
07-09-2020 |
|
|
VALID
|
|
CALCIFEDIOL |
H05BX05 |
DE
|
POM
|
|
|
|
VALID
|
|
CALCIUM CHLORIDE |
B05XA07 |
DE
|
POM
|
22-11-2023 |
DE/H/0200/001/II/010 |
17-01-2009 |
VALID
|
|
CANAGLIFLOZIN |
A10BK02 |
DE
|
POM
|
02-02-2018 |
|
|
VALID
|
|
CANNABINOIDS |
N02BG10 |
DE
|
POM
|
08-03-2018 |
|
|
VALID
|
|
CAPECITABINE |
L01BC06 |
DE
|
POM
|
|
|
|
VALID
|
|
CAPIVASERTIB |
L01EX27 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
CAPLACIZUMAB |
B01AX07 |
DE
|
POM
|
12-11-2018 |
EMEA/H/C/004426 |
27-08-2018 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CARBIMAZOLE |
H03BB01 |
DE
|
POM
|
|
|
|
VALID
|
|
CARIPRAZINE |
N05AX15 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/002770 |
13-07-2017 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
CEFIDEROCOL |
J01DI04 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004829 |
23-04-2020 |
VALID
|
|
CEFTAROLINE FOSAMIL |
J01DI02 |
DE
|
POM
|
19-10-2021 |
|
|
VALID
|
|
CEFTAZIDIME AND BETA-LACTAMASE INHIBITOR |
J01DD52 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004027 |
24-06-2016 |
VALID
|
|
CEFTOLOZANE AND BETA-LACTAMASE INHIBITOR |
J01DI54 |
DE
|
POM
|
|
|
|
VALID
|
|
CEFUROXIME |
J01DC02 |
DE
|
POM
|
30-05-2023 |
DE/H/0912/002/ |
02-06-2014 |
VALID
|
|
CELECOXIB |
M01AH01 |
DE
|
POM
|
12-10-2017 |
DE/H/3471/002/ |
09-09-2014 |
VALID
|
|
CEMIPLIMAB |
L01FF06 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004844 |
27-06-2019 |
VALID
|
|
CENEGERMIN |
S01XA24 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/004209 |
06-07-2017 |
VALID
|
|
CERLIPONASE ALFA |
A16AB17 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/004065 |
30-05-2017 |
VALID
|
